iHerb Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

iHerb

AsiaNet  90801

 

PASADENA, Calif., July 22, 2021 /PRNewswire=KYODO JBN/ --

 

iHerb Holdings, Inc. today announced that it has confidentially submitted a

draft registration statement on Form S-1 with the Securities and Exchange

Commission (the "SEC") relating to the proposed initial public offering of its

common stock. The number of shares to be offered and the price range for the

proposed offering have not yet been determined. The initial public offering is

expected to commence after the SEC completes its review process, subject to

market and other conditions.

 

Logo - https://mma.prnewswire.com/media/742063/iHerb_Logo.jpg

 

This press release does not constitute an offer to sell or the solicitation of

an offer to buy any securities. Any offers, solicitations or offers to buy, or

any sales of securities will be made in accordance with the registration

requirements of the Securities Act of 1933, as amended ("Securities Act"). This

announcement is being issued in accordance with Rule 135 under the Securities

Act.

 

About iHerb

 

We are the world's largest eCommerce platform dedicated to the Vitamins,

Minerals, Supplements, or VMS, category, with a growing presence in other areas

of consumer health and wellness. Trusted by millions in over 185 countries, we

offer a curated portfolio of branded and innovative third-party and proprietary

products at the best possible value, conveniently delivered directly to our

customers.

 

Source - iHerb

 

CONTACT:  Nicole Rohrer, Director, Brand and Content, press@iherb.com;

Cassandra Bujarski/Steven Goldberg, Sard Verbinnen & Co., iherb-SVC@sardverb.com

 

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中